메뉴 건너뛰기




Volumn 54, Issue 10, 2003, Pages 1343-1344+1349

Improving psychiatric drug benefit management: II. Kaiser Permanente's approach to SSRIs

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

EID: 10744223011     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ps.54.10.1343     Document Type: Article
Times cited : (9)

References (10)
  • 1
    • 0035293860 scopus 로고    scopus 로고
    • The controversy of increased spending for antidepressants
    • Croghan TW: The controversy of increased spending for antidepressants. Health Affairs 20(2):129-135, 2001
    • (2001) Health Affairs , vol.20 , Issue.2 , pp. 129-135
    • Croghan, T.W.1
  • 2
    • 0037263727 scopus 로고    scopus 로고
    • An ethical template for pharmacy benefits
    • Daniels N, Teagarden JR, Sabin JE: An ethical template for pharmacy benefits. Health Affairs 22(1):125-137, 2003
    • (2003) Health Affairs , vol.22 , Issue.1 , pp. 125-137
    • Daniels, N.1    Teagarden, J.R.2    Sabin, J.E.3
  • 3
    • 0038110732 scopus 로고    scopus 로고
    • Improving psychiatric drug benefit management: I. Lessons from Massachusetts
    • Sabin JE, Daniels N: Improving psychiatric drug benefit management: I. lessons from Massachusetts. Psychiatric Services 54:949-951, 2003
    • (2003) Psychiatric Services , vol.54 , pp. 949-951
    • Sabin, J.E.1    Daniels, N.2
  • 4
    • 0141562679 scopus 로고    scopus 로고
    • The depression initiative: An alliance to improve treatment
    • Fraser D: The depression initiative: an alliance to improve treatment. Permanente Journal 2(3):5-11, 1998
    • (1998) Permanente Journal , vol.2 , Issue.3 , pp. 5-11
    • Fraser, D.1
  • 5
    • 0029922652 scopus 로고    scopus 로고
    • Initial antidepressant choice in primary care: Effectiveness and cost of fluoxetine vs tricyclic antidepressants
    • Simon GE, VonKorff M, Heiligenstein JH, et al: Initial antidepressant choice in primary care: effectiveness and cost of fluoxetine vs tricyclic antidepressants. JAMA 275:1897-1902, 1996
    • (1996) JAMA , vol.275 , pp. 1897-1902
    • Simon, G.E.1    VonKorff, M.2    Heiligenstein, J.H.3
  • 6
    • 0036857290 scopus 로고    scopus 로고
    • Understanding changes in primary care clinicians' satisfaction from depression care activities during adoption of selective serotonin reuptake inhibitors
    • Shye D, Brown JB, Mullooly JP, et al: Understanding changes in primary care clinicians' satisfaction from depression care activities during adoption of selective serotonin reuptake inhibitors. American Journal of Managed Care 8:963-974, 2002
    • (2002) American Journal of Managed Care , vol.8 , pp. 963-974
    • Shye, D.1    Brown, J.B.2    Mullooly, J.P.3
  • 7
    • 0035915312 scopus 로고    scopus 로고
    • Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: A randomized trial
    • Kroenke K, West SL, Gilsenan A, et al: Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial. JAMA 286:2947-2955, 2001
    • (2001) JAMA , vol.286 , pp. 2947-2955
    • Kroenke, K.1    West, S.L.2    Gilsenan, A.3
  • 8
    • 0035915317 scopus 로고    scopus 로고
    • Choosing a first-line antidepressant: Equal on average does not mean equal for everyone
    • Simon G: Choosing a first-line antidepressant: equal on average does not mean equal for everyone. JAMA 286:3003-3004, 2001
    • (2001) JAMA , vol.286 , pp. 3003-3004
    • Simon, G.1
  • 9
    • 0034145174 scopus 로고    scopus 로고
    • Kaiser Permanente's prescription drug benefit
    • Levine S, Campen D, Millares M, et al: Kaiser Permanente's prescription drug benefit. Health Affairs 19(2):185-190, 2000
    • (2000) Health Affairs , vol.19 , Issue.2 , pp. 185-190
    • Levine, S.1    Campen, D.2    Millares, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.